KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Common Equity (2020 - 2025)

Oscar Health's Common Equity history spans 6 years, with the latest figure at $977.6 million for Q4 2025.

  • For Q4 2025, Common Equity fell 3.82% year-over-year to $977.6 million; the TTM value through Dec 2025 reached $977.6 million, down 3.82%, while the annual FY2025 figure was $977.6 million, 3.82% down from the prior year.
  • Common Equity reached $977.6 million in Q4 2025 per OSCR's latest filing, down from $1.0 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $3.7 billion in Q1 2024 to a low of -$2.9 million in Q4 2022.
  • Average Common Equity over 5 years is $1.3 billion, with a median of $1.1 billion recorded in 2022.
  • Peak YoY movement for Common Equity: crashed 155.22% in 2022, then surged 27678.41% in 2023.
  • A 5-year view of Common Equity shows it stood at $5.3 million in 2021, then plummeted by 155.22% to -$2.9 million in 2022, then soared by 27678.41% to $806.1 million in 2023, then rose by 26.09% to $1.0 billion in 2024, then decreased by 3.82% to $977.6 million in 2025.
  • Per Business Quant, the three most recent readings for OSCR's Common Equity are $977.6 million (Q4 2025), $1.0 billion (Q3 2025), and $2000.0 (Q1 2025).